A modular map of Bradykinin-mediated inflammatory signaling network.

Astuti I and Ysrafil (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr 14(4):407–412

Barnes PJ (1992) Bradykinin and asthma. Thorax 47(11):979–983

pubmed: 1465760 pmcid: 464122

Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G (2007) Nonallergic angioedema: role of bradykinin. Allergy 62(8):842–856

pubmed: 17620062

Blaes N, Girolami JP (2013) Targeting the “Janus face” of the B2-bradykinin receptor. Expert Opin Ther Targets 17(10):1145–1166

pubmed: 23957374

Bossi F, Fischetti F, Regoli D, Durigutto P, Frossi B, Gobeil F Jr, Ghebrehiwet B, Peerschke EI, Cicardi M, Tedesco F (2009) Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol 124(6):1303–1310

pubmed: 19796797 pmcid: 2798851

Campbell DJ, Alexiou T, Xiao HD, Fuchs S, McKinley MJ, Corvol P, Bernstein KE (2004) Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension 43(4):854–859

pubmed: 14769811

Chen BC, Yu CC, Lei HC, Chang MS, Hsu MJ, Huang CL, Chen MC, Sheu JR, Chen TF, Chen TL, Inoue H, Lin CH (2004) Bradykinin B2 receptor mediates NF-kappaB activation and cyclooxygenase-2 expression via the Ras/Raf-1/ERK pathway in human airway epithelial cells. J Immunol 173(8):5219–5228

pubmed: 15470067

Chu E, Saini S, Liu T, Yoo J (2017) Bradykinin stimulates protein kinase D-mediated colonic myofibroblast migration via cyclooxygenase-2 and heat shock protein 27. J Surg Res 209:191–198

pubmed: 28032559

Clerk A, Gillespie-Brown J, Fuller SJ, Sugden PH (1996) Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response. Biochem J 317(Pt 1):109–118

pubmed: 8694751 pmcid: 1217450

Couture R, Harrisson M, Vianna RM, Cloutier F (2001) Kinin receptors in pain and inflammation. Eur J Pharmacol 429(1–3):161–176

pubmed: 11698039

da Costa PL, Sirois P, Tannock IF, Chammas R (2014) The role of kinin receptors in cancer and therapeutic opportunities. Cancer Lett 345(1):27–38

pubmed: 24333733

Dagamajalu S, Rex DAB, Gopalakrishnan L, Karthikkeyan G, Gurtoo S, Modi PK, Mohanty V, Mujeeburahiman M, Soman S, Raju R, Tiwari V, Prasad TSK (2021a) A network map of endothelin mediated signaling pathway. J Cell Commun Signal 15(2):277–282

pubmed: 32915369

Dagamajalu S, Rex DAB, Palollathil A, Shetty R, Bhat G, Cheung LWT, Prasad TSK (2021b) A pathway map of AXL receptor-mediated signaling network. J Cell Commun Signal 15(1):143–148

pubmed: 32829427

Dagnino APA, Campos MM, Silva RBM (2020) Kinins and their receptors in infectious diseases. Pharmaceuticals (basel) 13(9):215

Davoine C, Bouckaert C, Fillet M, Pochet L (2020) Factor XII/XIIa inhibitors: their discovery, development, and potential indications. Eur J Med Chem 208:112753

pubmed: 32883641

Dey G, Radhakrishnan A, Syed N, Thomas JK, Nadig A, Srikumar K, Mathur PP, Pandey A, Lin SK, Raju R, Prasad TS (2013) Signaling network of oncostatin M pathway. J Cell Commun Signal 7(2):103–108

pubmed: 23255051

Dong R, Chen W, Feng W, Xia C, Hu D, Zhang Y, Yang Y, Wang DW, Xu X, Tu L (2015) Exogenous bradykinin inhibits tissue factor induction and deep vein thrombosis via activating the eNOS/Phosphoinositide 3-Kinase/Akt signaling pathway. Cell Physiol Biochem 37(4):1592–1606

pubmed: 26517864

Drouin JN, St-Pierre SA, Regoli D (1979) Receptors for bradykinin and kallidin. Can J Physiol Pharmacol 57(4):375–379

pubmed: 455136

Duchene J, Lecomte F, Ahmed S, Cayla C, Pesquero J, Bader M, Perretti M, Ahluwalia A (2007) A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5. J Immunol 179(7):4849–4856

pubmed: 17878384

Ehrenfeld P, Conejeros I, Pavicic MF, Matus CE, Gonzalez CB, Quest AF, Bhoola KD, Poblete MT, Burgos RA, Figueroa CD (2011) Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells. Cancer Lett 301(1):106–118

pubmed: 21147512

Falsetta ML, Foster DC, Woeller CF, Pollock SJ, Bonham AD, Haidaris CG, Phipps RP (2016) A role for bradykinin signaling in chronic vulvar pain. J Pain 17(11):1183–1197

pubmed: 27544818 pmcid: 6226004

Farkas H, Varga L (2011) Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency. Clin Cosmet Investig Dermatol 4:61–68

pubmed: 21760740 pmcid: 3133501

Fong D, Smith DI, Hsieh WT (1991) The human kininogen gene (KNG) mapped to chromosome 3q26-qter by analysis of somatic cell hybrids using the polymerase chain reaction. Hum Genet 87(2):189–192

pubmed: 2066106

Garvin MR, Alvarez C, Miller JI, Prates ET, Walker AM, Amos BK, Mast AE, Justice A, Aronow B, Jacobson D (2020) A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife 9:e59177. https://doi.org/10.7554/eLife.59177

Graness A, Adomeit A, Ludwig B, Muller WD, Kaufmann R, Liebmann C (1997) Novel bradykinin signalling events in PC-12 cells: stimulation of the cAMP pathway leads to cAMP-mediated translocation of protein kinase Cepsilon. Biochem J 327(Pt 1):147–154

pubmed: 9355746 pmcid: 1218774

Graness A, Adomeit A, Heinze R, Wetzker R, Liebmann C (1998) A novel mitogenic signaling pathway of bradykinin in the human colon carcinoma cell line SW-480 involves sequential activation of a Gq/11 protein phosphatidylinositol 3-kinase β and protein kinase Cε. J Biol Chem 273(48):32016–32022. https://doi.org/10.1074/jbc.273.48.32016

doi: 10.1074/jbc.273.48.32016 pubmed: 9822674

Greco S, Muscella A, Elia MG, Romano S, Storelli C, Marsigliante S (2004) Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells. J Cell Physiol 201(1):84–96

pubmed: 15281091

Greco S, Elia MG, Muscella A, Romano S, Storelli C, Marsigliante S (2005) Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J Endocrinol 186(2):291–301

pubmed: 16079255

Greco S, Storelli C, Marsigliante S (2006) Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin. J Endocrinol 188(1):79–89

pubmed: 16394177

Hofman Z, de Maat S, Hack CE, Maas C (2016a) Bradykinin: inflammatory product of the coagulation system. Clin Rev Allergy Immunol 51(2):152–161

pubmed: 27122021 pmcid: 5025506

Hofman ZL, Relan A, Zeerleder S, Drouet C, Zuraw B, Hack CE (2016b) Angioedema attacks in patients with hereditary angioedema: local manifestations of a systemic activation process. J Allergy Clin Immunol 138(2):359–366

pubmed: 27246526

Hsieh HL, Wang HH, Wu CY, Jou MJ, Yen MH, Parker P, Yang CM (2007) BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes. Cell Signal 19(2):330–340

pubmed: 16935468

Huang CD, Tliba O, Panettieri RA Jr, Amrani Y (2003) Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol 28(3):330–338

pubmed: 12594059

Izumi S, Higa-Nakamine S, Nishi H, Torihara H, Uehara A, Sugahara K, Kakinohana M, Yamamoto H (2018) Phosphorylation of epidermal growth factor receptor at serine 1047 in cultured lung alveolar epithelial cells by bradykinin B2 receptor stimulation. Pulm Pharmacol Ther 48:53–61

pubmed: 28899709

Jaffa MA, Kobeissy F, Al Hariri M, Chalhoub H, Eid A, Ziyadeh FN, Jaffa AA (2012) Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes. PLoS ONE 7(9):e44714

pubmed: 23028588 pmcid: 3445541

Jalowy A, Schulz R, Dorge H, Behrends M, Heusch G (1998) Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol 32(6):1787–1796

pubmed: 9822110

Kakoki M, Smithies O (2009) The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int 75(10):1019–1030

pubmed: 19190676 pmcid: 3733452

Kandasamy K, Keerthikumar S, Raju R, Keshava Prasad TS, Ramachandra YL, Mohan S, Pandey A (2009) PathBuilder–open source software for annotating and developing pathway resources. Bioinformatics 25(21):2860–2862

pubmed: 19628504 pmcid: 2781757

Kandasamy K, Mohan SS, Raju R, Keerthikumar S, Kumar GS, Venugopal AK, Telikicherla D, Navarro JD, Mathivanan S, Pecquet C, Gollapudi SK, Tattikota SG, Mohan S, Padhukasahasram H, Subbannayya Y, Goel R, Jacob HK, Zhong J, Sekhar R, Nanjappa V, Balakrishnan L, Subbaiah R, Ramachandra YL, Rahiman BA, Prasad TS, Lin JX, Houtman JC, Desiderio S, Renauld JC, Constantinescu SN, Ohara O, Hirano T, Kubo M, Singh S, Khatri P, Draghici S, Bader GD, Sander C, Leonard WJ, Pandey A (2010) NetPath: a public resource of curated signal transduction pathways. Genome Biol 11(1):R3

pubmed: 20067622 pmcid: 2847715

Kaplan AP, Joseph K, Silverberg M (2002) Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 109(2):195–209

pubmed: 11842287

Kenniston JA, Faucette RR, Martik D, Comeau SR, Lindberg AP, Kopacz KJ, Conley GP, Chen J, Viswanathan M, Kastrapeli N, Cosic J, Mason S, DiLeo M, Abendroth J, Kuzmic P, Ladner RC, Edwards TE, TenHoor C, Adelman BA, Nixon AE, Sexton DJ (2014) Inhibition of plasma kallikrein by a highly specific active site blocking antibody. J Biol Chem 289(34):23596–23608

pubmed: 24970892 pmcid: 4156074

Khasar SG, Miao FJ, Levine JD (1995) Inflammation modulates the contribution of receptor-subtypes to bradykinin-induced hyperalgesia in the rat. Neuroscience 69(2):685–690

pubmed: 8552260

Kmietowicz Z (2018) ACE inhibitors are linked to increased lung cancer risk, study finds. BMJ 363:k4471

pubmed: 30355572

Kramarenko II, Morinelli TA, Bunni MA, Raymond JR Sr, Garnovskaya MN (2012) The bradykinin B(2) receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines. Cancer Manag Res 4:195–205

pubmed: 22904641 pmcid: 3421467

Krankel N, Katare RG, Siragusa M, Barcelos LS, Campagnolo P, Mangialardi G, Fortunato O, Spinetti G, Tran N, Zacharowski K, Wojakowski W, Mroz I, Herman A, Manning Fox JE, MacDonald PE, Schanstra JP, Bascands JL, Ascione R, Angelini G, Emanueli C, Madeddu P (2008) Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res 103(11):1335–1343

pubmed: 18927465 pmcid: 2821015

Kutmon M, van Iersel MP, Bohler A, Kelder T, Nunes N, Pico AR, Evelo CT (2015) PathVisio 3: an extendable pathway analysis toolbox. PLoS Comput Biol 11(2):e1004085

pubmed: 25706687 pmcid: 4338111

Lau J, Rousseau J, Kwon D, Benard F, Lin KS (2020) A systematic review of molecular imaging agents targeting bradykinin B1 and B2 receptors. Pharmaceuticals (basel) 13(8):199

Lee CH, Shieh DC, Tzeng CY, Chen CP, Wang SP, Chiu YC, Huang CY, Hsu CJ, Fong YC, Tang CH (2008) Bradykinin-induced IL-6 expression through bradykinin B2 receptor, phospholipase C, protein kinase Cdelta and NF-kappaB pathway in human synovial fibroblasts. Mol Immunol 45(14):3693–3702

pubmed: 18621420

Lee K, Kim YJ, Choi LM, Choi S, Nam H, Ko HY, Chung G, Lee JH, Jo SH, Lee G, Choi SY, Park K (2017) Human salivary gland cells express bradykinin receptors that modulate the expression of proinflammatory cytokines. Eur J Oral Sci 125(1):18–27

pubmed: 28032657

Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL (2005) International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57(1):27–77

pubmed: 15734727

Lesage A, Gibson C, Marceau F, Ambrosi HD, Saupe J, Katzer W, Loenders B, Charest-Morin X, Knolle J (2020) In vitro pharmacological profile of a new small molecule bradykinin B2 receptor antagonist. Front Pharmacol 11:916

pubmed: 32636746 pmcid: 7316994

Li G, Wang Y, Li GR (2017) Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cells. Oncotarget 8(7):10822–10835

pubmed: 28099911 pmcid: 5355226

Li G, Che H, Wu WY, Jie LJ, Xiao GS, Wang Y, Li GR (2018) Bradykinin-mediated Ca(2+) signalling regulates cell growth and mobility in human cardiac c-Kit(+) progenitor cells. J Cell Mol Med 22(10):4688–4699

pubmed: 30117680 pmcid: 6156395

Lim SK, Park MJ, Jung HK, Park AY, Kim DI, Kim JC, Bae CS, Kim KY, Yoon KC, Han HJ, Park SH (2008) Bradykinin stimulates glutamate uptake via both B1R and B2R activation in a human retinal pigment epithelial cells. Life Sci 83(23–24):761–770

pubmed: 18948121

Manning ME, Kashkin JM (2021) Berotralstat (BCX7353) is a novel oral prophylactic treatment for hereditary angioedema: Review of phase II and III studies. Allergy Asthma Proc 42(4):274–282

pubmed: 34127176

Marceau F, Sabourin T, Houle S, Fortin JP, Petitclerc E, Molinaro G, Adam A (2002) Kinin receptors: functional aspects. Int Immunopharmacol 2(13–14):1729–1739

pubmed: 12489786

Marceau F, Bachelard H, Bouthillier J, Fortin JP, Morissette G, Bawolak MT, Charest-Morin X, Gera L (2020) Bradykinin receptors: agonists, antagonists, expression, signaling, and adaptation to sustained stimulation. Int Immunopharmacol 82:106305

pubmed: 32106060

Meini S, Cucchi P, Catalani C, Bellucci F, Giuliani S, Maggi CA (2011) Bradykinin and B(2) receptor antagonism in rat and human articular chondrocytes. Br J Pharmacol 162(3):611–622

pubmed: 20946124 pmcid: 3041251

Moraes MS, Costa PE, Batista WL, Paschoalin T, Curcio MF, Borges RE, Taha MO, Fonseca FV, Stern A, Monteiro HP (2014) Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis. Arch Biochem Biophys 558:14–27. https://doi.org/10.1016/j.abb.2014.06.011

doi: 10.1016/j.abb.2014.06.011 pubmed: 24960080

Motta Junior JDS, Miggiolaro A, Nagashima S, de Paula CBV, Baena CP, Scharfstein J, de Noronha L (2020) Mast cells in alveolar septa of COVID-19 patients: a pathogenic pathway that may link interstitial edema to immunothrombosis. Front Immunol 11:574862

pubmed: 33042157 pmcid: 7530169

Naffah-Mazzacoratti Mda G, Gouveia TL, Simoes PS, Perosa SR (2014) What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders? World J Biol Chem 5(2):130–140

pubmed: 24921004

Nokkari A, Abou-El-Hassan H, Mechref Y, Mondello S, Kindy MS, Jaffa AA, Kobeissy F (2018) Implication of the Kallikrein–Kinin system in neurological disorders: quest for potential biomarkers and mechanisms. Prog Neurobiol 165–167:26–50

pubmed: 29355711 pmcid: 6026079

Paegelow I, Werner H, Vietinghoff G, Wartner U (1995) Release of cytokines from isolated lung strips by bradykinin. Inflamm Res 44(7):306–311

pubmed: 8564529

Pan ZK, Zuraw BL, Lung CC, Prossnitz ER, Browning DD, Ye RD (1996) Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts. J Clin Invest 98(9):2042–2049

pubmed: 8903323 pmcid: 507648

Pinto SM, Subbannayya Y, Rex DAB, Raju R, Chatterjee O, Advani J, Radhakrishnan A, Keshava Prasad TS, Wani MR, Pandey A (2018) A network map of IL-33 signaling pathway. J Cell Commun Signal 12(3):615–624

pubmed: 29705949 pmcid: 6039344

Qadri F, Bader M (2018) Kinin B1 receptors as a therapeutic target for inflammation. Expert Opin Ther Targets 22(1):31–44

pubmed: 29168929

Raju R, Nanjappa V, Balakrishnan L, Radhakrishnan A, Thomas JK, Sharma J, Tian M, Palapetta SM, Subbannayya T, Sekhar NR, Muthusamy B, Goel R, Subbannayya Y, Telikicherla D, Bhattacharjee M, Pinto SM, Syed N, Srikanth MS, Sathe GJ, Ahmad S, Chavan SN, Kumar GS, Marimuthu A, Prasad TS, Harsha HC, Rahiman BA, Ohara O, Bader GD, Sujatha Mohan S, Schiemann WP, Pandey A (2011) NetSlim: high-confidence curated signaling maps. Database (oxford) 2011:bae032

Rex DAB, Agarwal N, Prasad TSK, Kandasamy RK, Subbannayya Y, Pinto SM (2020) A comprehensive pathway map of IL-18-mediated signalling. J Cell Commun Signal 14(2):257–266

pubmed: 31863285

Rex DAB, Dagamajalu S, Kandasamy RK, Raju R, and Prasad, TSK (2021) SARS-CoV-2 signaling pathway map: A functional landscape of molecular mechanisms in COVID-19. J Cell Commun Signal

Ricciardolo FLM, Folkerts G, Folino A, Mognetti B (2018) Bradykinin in asthma: modulation of airway inflammation and remodelling. Eur J Pharmacol 827:181–188

pubmed: 29548973

Roche JA, Roche R (2020) A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. FASEB J 34(6):7265–7269

pubmed: 32359101

Sancho-Bru P, Bataller R, Fernandez-Varo G, Moreno M, Ramalho LN, Colmenero J, Mari M, Claria J, Jimenez W, Arroyo V, Brenner DA, Gines P (2007) Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury. Gastroenterology 133(6):2019–2028

pubmed: 18054572

Saoud R, Jaffa MA, Habib A, Zhao J, Al Hariri M, Zhu R, Hasan A, Ziyadeh FN, Kobeissy F, Mechref Y, Jaffa AA (2020) Modulation of proteomic and inflammatory signals by Bradykinin in podocytes. J Adv Res 24:409–422

pubmed: 32518694 pmcid: 7270529

Sharif NA, Xu S, Li L, Katoli P, Kelly CR, Wang Y, Cao S, Patil R, Husain S, Klekar L, Scott D (2013) Protein expression, biochemical pharmacology of signal transduction, and relation to intraocular pressure modulation by bradykinin B(2) receptors in ciliary muscle. Mol vis 19:1356–1370

pubmed: 23805043 pmcid: 3693772

Singh PK, Chen ZL, Ghosh D, Strickland S, Norris EH (2020a) Increased plasma bradykinin level is associated with cognitive impairment in Alzheimer’s patients. Neurobiol Dis 139:104833

pubmed: 32173555 pmcid: 7175647

Singh PK, Chen ZL, Strickland S, Norris EH (2020b) Increased contact system activation in mild cognitive impairment patients with impaired short-term memory. J Alzheimers Dis 77(1):59–65

pubmed: 32651324 pmcid: 7587041

Soman S, Raju R, Sandhya VK, Advani J, Khan AA, Harsha HC, Prasad TS, Sudhakaran PR, Pandey A, Adishesha PK (2013) A multicellular signal transduction network of AGE/RAGE signaling. J Cell Commun Signal 7(1):19–23

pubmed: 23161412

Stewart JM, Gera L, Chan DC, Bunn PA Jr, York EJ, Simkeviciene V, Helfrich B (2002) Bradykinin-related compounds as new drugs for cancer and inflammation. Can J Physiol Pharmacol 80(4):275–280

pubmed: 12025961

Tan Y, Wang B, Keum JS, Jaffa AA (2005) Mechanisms through which bradykinin promotes glomerular injury in diabetes. Am J Physiol Renal Physiol 288(3):F483–F492

pubmed: 15692059

Tanabe A, Shiraishi M, Negishi M, Saito N, Tanabe M, Sasaki Y (2012) MARCKS dephosphorylation is involved in bradykinin-induced neurite outgrowth in neuroblastoma SH-SY5Y cells. J Cell Physiol 227(2):618–629

pubmed: 21448919

Terzuoli E, Corti F, Nannelli G, Giachetti A, Donnini S, Ziche M (2018) Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1. Int J Mol Sci 19(9):2638

pmcid: 6163484

Tschope C, Schultheiss HP, Walther T (2002) Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade. J Cardiovasc Pharmacol 39(4):478–487

pubmed: 11904521

Vandell AG, Larson N, Laxmikanthan G, Panos M, Blaber SI, Blaber M, Scarisbrick IA (2008) Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines. J Neurochem 107(3):855–870

pubmed: 18778305 pmcid: 2692621

Verma R, Balakrishnan L, Sharma K, Khan AA, Advani J, Gowda H, Tripathy SP, Suar M, Pandey A, Gandotra S, Prasad TS, Shankar S (2016) A network map of Interleukin-10 signaling pathway. J Cell Commun Signal 10(1):61–67

pubmed: 26253919

Virych PA, Shelyuk OV, Kabanova TA, Khalimova EI, Martynyuk VS, Pavlovsky VI, Andronati SA (2017) Effect of 3-substituted 1,4-benzodiazepin-2-ones on bradykinin-induced smooth muscle contraction. Ukr Biochem J 89(1):31–37

pubmed: 29236387

Wang S, Dai Y, Fukuoka T, Yamanaka H, Kobayashi K, Obata K, Cui X, Tominaga M, Noguchi K (2008) Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain. Brain 131(Pt 5):1241–1251

pubmed: 18356188

Wang G, Ye Y, Zhang X, Song J (2014) Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells. Oncol Rep 32(4):1709–1714

pubmed: 25109623

Wang G, Sun J, Liu G, Fu Y, Zhang X (2017) Bradykinin promotes cell proliferation, migration, invasion, and tumor growth of gastric cancer through ERK signaling pathway. J Cell Biochem 118(12):4444–4453

pubmed: 28464378

Wang W, Zhou Y, Wei R, Jiang G, Li F, Chen X, Wang X, Ma D, Xi L (2019) Bradykinin promotes proliferation migration and invasion of cervical cancer cells through STAT3 signaling pathways. Oncol Rep. https://doi.org/10.3892/or.2019.7380

doi: 10.3892/or.2019.7380 pubmed: 31894346 pmcid: 6967104

Webb JG, Yang X, Crosson CE (2011) Bradykinin activation of extracellular signal-regulated kinases in human trabecular meshwork cells. Exp Eye Res 92(6):495–501

pubmed: 21426904 pmcid: 3104070

Wedner HJ, Aygoren-Pursun E, Bernstein J, Craig T, Gower R, Jacobs JS, Johnston DT, Lumry WR, Zuraw BL, Best JM, Iocca HA, Murray SC, Desai B, Nagy E, Sheridan WP, Kiani-Alikhan S (2021) Randomized trial of the efficacy and safety of berotralstat (BCX7353) as an oral prophylactic therapy for hereditary angioedema: results of APeX-2 through 48 weeks (Part 2). J Allergy Clin Immunol Pract 9(6):2305-2314e4

pubmed: 33866032

Whalley ET, Figueroa CD, Gera L, Bhoola KD (2012) Discovery and therapeutic potential of kinin receptor antagonists. Expert Opin Drug Discov 7(12):1129–1148

pubmed: 23095011

Wilczynski SA, Wenceslau CF, McCarthy CG, Webb RC (2021) A cytokine/bradykinin storm comparison: What is the relationship between hypertension and COVID-19? Am J Hypertens 34(4):304–306

pubmed: 33877321

Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, Henk S, Breipohl G, Konig W, Knolle J et al (1991) Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol 102(3):774–777

pubmed: 1364852 pmcid: 1917928

Xie P, Browning DD, Hay N, Mackman N, Ye RD (2000) Activation of NF-κB by bradykinin through a Gα

doi: 10.1074/jbc.M001051200 pubmed: 10801799

Yang W-H, Jung-Tzu, Chang Sheng-Feng, Hsu Te-Mao, Li Der-Yang, Cho Chun-Yin, Huang Yi-Chin, Fong Chih-Hsin, Tang (2009) Bradykinin enhances cell migration in human chondrosarcoma cells through BK receptor signaling pathways. J Cell Biochem https://doi.org/10.1002/jcb.22383

doi: 10.1002/jcb.22383 pubmed: 19795389 pmcid: 2833326

Yang L, Zhang J, Li N, Xie H, Chen S, Wang H, Shen T, Zhu QX (2018) Bradykinin receptor in immune-mediated renal tubular injury in trichloroethylene-sensitized mice: impact on NF-kappaB signaling pathway. J Immunotoxicol 15(1):126–136

pubmed: 30409067

Yu HS, Lin TH, Tang CH (2013) Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCdelta/c-Src dependent signaling pathway. Prostate 73(1):89–100

pubmed: 22653778

Yu HS, Wang SW, Chang AC, Tai HC, Yeh HI, Lin YM, Tang CH (2014) Bradykinin promotes vascular endothelial growth factor expression and increases angiogenesis in human prostate cancer cells. Biochem Pharmacol 87(2):243–253

pubmed: 24225154

Zhang W, Bhola N, Kalyankrishna S, Gooding W, Hunt J, Seethala R, Grandis JR, Siegfried JM (2008) Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas. Mol Cancer Res 6(12):1946–1956

pubmed: 19074839 pmcid: 3575100

Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46(4):586–590

pubmed: 32125455 pmcid: 7079879

Zhu YM, Bradbury DA, Pang L, Knox AJ (2003) Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoid-independent activation of NF-kappaB. J Biol Chem 278(31):29366–29375

pubmed: 12748173

Zhu L, Carretero OA, Liao TD, Harding P, Li H, Sumners C, Yang XP (2010) Role of prolylcarboxypeptidase in angiotensin II type 2 receptor-mediated bradykinin release in mouse coronary artery endothelial cells. Hypertension 56(3):384–390

pubmed: 20606103

Zuraw B, Lumry WR, Johnston DT, Aygoren-Pursun E, Banerji A, Bernstein JA, Christiansen SC, Jacobs JS, Sitz KV, Gower RG, Gagnon R, Wedner HJ, Kinaciyan T, Hakl R, Hanzlikova J, Anderson JT, McNeil DL, Fritz SB, Yang WH, Tachdjian R, Busse PJ, Craig TJ, Li HH, Farkas H, Best JM, Clemons D, Cornpropst M, Dobo SM, Iocca HA, Kargl D, Nagy E, Murray SC, Collis P, Sheridan WP, Maurer M, Riedl MA (2021) Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial. J Allergy Clin Immunol 148(1):164–1729

pubmed: 33098856

A modular map of Bradykinin-mediated inflammatory signaling network.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Pagination

Informations de copyright

Références

Auteurs

D A B Rex (DAB)

K Deepak (K)

Neelanchal Vaid (N)

Shobha Dagamajalu (S)

Richard Kumaran Kandasamy (RK)

Trude Helen Flo (TH)

T S Keshava Prasad (TS)

Classifications MeSH